REFERENCES
- American Heart Association. Heart disease and stroke statistics—2005 update. AHA, Dallas, TX 2005
- World Health Organization. The world health report 2002: reducing risks, promoting healthy life. WHO, Geneva 2002
- Cassem N H, Hackett T P. Psychological aspects of myocardial infarction. Med Clin North Am 1977; 61: 711–21, [INFOTRIEVE], [CSA]
- Hackett T P, Cassem N H. Psychological management of the myocardial infarction patient. J Human Stress 1975; 1: 25–38, [INFOTRIEVE], [CSA]
- Friedman M, Powell L H, Thoresen C E, et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112: 453–65, [CROSSREF], [CSA]
- Friedman M, Powell L H, Thoresen C E, et al. Effect of discontinuance of type A behavioral counseling on type A behavior and cardiac recurrence rate of post myocardial infarction patients. Am Heart J 1987; 114: 483–90, [INFOTRIEVE], [CROSSREF], [CSA]
- Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270: 1819–25, [INFOTRIEVE], [CROSSREF], [CSA]
- Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999–1005, [INFOTRIEVE], [CSA]
- Carney R M, Freedland K E. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003; 54: 241–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Ziegelstein R C. Depression after myocardial infarction. Cardiol Rev 2001; 9: 45–51, [INFOTRIEVE], [CROSSREF], [CSA]
- Roose S P. Treatment of depression in patients with heart disease. Biol Psychiatry 2003; 54: 262–8, [INFOTRIEVE], [CROSSREF], [CSA]
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. APA, Washington, DC 1994
- Spijkerman T A, van den Brink R H, Jansen J H, Crijns H J, Ormel J. Who is at risk of post-MI depressive symptoms?. J Psychosom Res 2005; 58: 425–32, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Honig A, Maes M. Depression and myocardial infarction: relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 879–92, [INFOTRIEVE], [CROSSREF], [CSA]
- Glassman A H, O'Connor C M, Califf R M, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701–9, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62: 783–9, [INFOTRIEVE], [CSA]
- Berkman L F, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106–16, [INFOTRIEVE], [CROSSREF], [CSA]
- Honig A, Lousberg R, Wojchiechowski F, Cheriex E C, Wellens H, Van Praag H M. Depression following a first heart infarct: similarities with and difference from ‘ordinary’ depression. Ned T Geneeskunde 1997; 141: 196–9, [CSA]
- Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000; 48: 379–91, [INFOTRIEVE], [CROSSREF], [CSA]
- Dijkstra J B, Strik J J, Lousberg R, et al. Atypical cognitive profile in patients with depression after myocardial infarction. J Affect Disord 2002; 70: 181–90, [INFOTRIEVE], [CROSSREF], [CSA]
- Alexopoulos G S, Meyers B S, Young R C, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997; 54: 915–22, [INFOTRIEVE], [CSA]
- Alexopoulos G S, Meyers B S, Young R C, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry 1997; 154: 562–5, [INFOTRIEVE], [CSA]
- Taragano F E, Bagnatti P, Allegri R F. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. Int Psychogeriatr 2005; 17: 487–98, [INFOTRIEVE], [CROSSREF], [CSA]
- Van Praag H M. Anxiety/aggression–driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 893–924, [INFOTRIEVE], [CROSSREF], [CSA]
- Beck A T, Ward C H, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71, [INFOTRIEVE], [CSA]
- Appels A. Exhaustion and coronary heart disease: the history of a scientific quest. Patient Educ Couns 2004; 55: 223–9, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001; 42: 423–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Derogatis L R, Lipman R S, Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull 1973; 9: 13–28, [INFOTRIEVE], [CSA]
- Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70, [INFOTRIEVE], [CSA]
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62, [INFOTRIEVE], [CSA]
- Bambauer K Z, Locke S E, Aupont O, Mullan M G, McLaughlin T J. Using the Hospital Anxiety and Depression Scale to screen for depression in cardiac patients. Gen Hosp Psychiatry 2005; 27: 275–84, [INFOTRIEVE], [CROSSREF], [CSA]
- Freedland K E, Skala J A, Carney R M, et al. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002; 64: 897–905, [INFOTRIEVE], [CROSSREF], [CSA]
- Spitzer R L, Kroenke K, Williams J B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 28: 1737–44, [CROSSREF], [CSA]
- Kroenke K, Spitzer R L, Williams J B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–13, [INFOTRIEVE], [CROSSREF], [CSA]
- Williams L S, Brizendine E J, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005; 36: 635–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Robins L N, Helzer J E, Ratcliff K S, Seyfried W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychol Med 1982; 12: 855–70, [INFOTRIEVE], [CSA]
- Zung W W, Richards C B, Short M J. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508–15, [INFOTRIEVE], [CSA]
- Radloff L S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401, [CSA]
- Strik J J, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003; 42: 1801–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Ahern D K, Gorkin L, Anderson J L, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 59–62, [INFOTRIEVE], [CROSSREF], [CSA]
- Shiotani I, Sato H, Kinjo K, et al. Osaka Acute Coronary Insufficiency Study (OACIS) Group. Depressive symptoms predict 12-month prognosis in elderly patients with acute myocardial infarction. J Cardiovasc Risk 2002; 9: 153–60, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Lousberg R, Cheriex E C, Honig A. One-year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res 2004; 56: 59–66, [INFOTRIEVE], [CROSSREF], [CSA]
- Kubzansky L D, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease?. J Psychosom Res 2000; 48: 323–37, [INFOTRIEVE], [CROSSREF], [CSA]
- Kubzansky L D, Kawachi I, Spiro A, Weiss S T, Vokonas P S, Sparrow D. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997; 95: 818–24, [INFOTRIEVE], [CSA]
- Eaker E D, Pinsky J, Castelli W P. Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am J Epidemiol 1992; 135: 854–64, [INFOTRIEVE], [CSA]
- Moser D K, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?. Psychosom Med 1996; 58: 395–401, [INFOTRIEVE], [CSA]
- Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?. Health Psychol 1995; 14: 388–98, [INFOTRIEVE], [CROSSREF], [CSA]
- Grace S L, Abbey S E, Irvine J, Shnek Z M, Stewart D E. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004; 73: 344–52, [INFOTRIEVE], [CROSSREF], [CSA]
- Mayou R A, Gill D, Thompson D R, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212–9, [INFOTRIEVE], [CSA]
- Lane D, Carroll D, Ring C, Beevers D G, Lip G Y. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221–30, [INFOTRIEVE], [CSA]
- Wittchen H U, Kessler R C, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand 2000; 406: 14–23, [CROSSREF], [CSA]
- Kim K A, Moser D K, Garvin B J, et al. Differences between men and women in anxiety early after acute myocardial infarction. Am J Crit Care 2000; 9: 245–53, [INFOTRIEVE], [CSA]
- Kennedy B L, Schwab J J, Morris R L, Beldia G. Assessment of state and trait anxiety in subjects with anxiety and depressive disorders. Psychiatr Q 2001; 72: 263–76, [INFOTRIEVE], [CROSSREF], [CSA]
- Huffman J C, Stern T A. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med 2003; 25: 427–37, [INFOTRIEVE], [CSA]
- Mookadam F, Arthur H M. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med 2004; 164: 1514–8, [INFOTRIEVE], [CSA]
- Frasure-Smith F, Lesperance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000; 101: 1919–24, [INFOTRIEVE], [CSA]
- Koskenvuo M, Kaprio J, Rose R J, et al. Hostility as a risk factor for mortality and ischemic heart disease in men. Psychosom Med 1988; 50: 330–40, [INFOTRIEVE], [CSA]
- Chaput L A, Adams S H, Simon J A, et al. Hostility predicts recurrent events among postmenopausal women with coronary heart disease. Am J Epidemiol 2002; 156: 1092–9, [INFOTRIEVE], [CROSSREF], [CSA]
- Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003; 60: 627–36, [INFOTRIEVE], [CROSSREF], [CSA]
- Ketterer M W, Huffman J, Lumley M A, et al. Five-year follow-up for adverse outcomes in males with at least minimally positive angiograms: importance of “denial” in assessing psychosocial risk factors. J Psychosom Res 1998; 44: 241–50, [INFOTRIEVE], [CROSSREF], [CSA]
- Kubzansky L D, Davidson K W, Rozanski A. The clinical impact of negative psychological states: expanding the spectrum of risk for coronary artery disease. Psychosom Med 2005; 67: S10–4, [INFOTRIEVE], [CROSSREF], [CSA]
- Ketterer M W, Denollet J, Goldberg A D, et al. The big mush: psychometric measures are confounded and non-independent in their association with age at initial diagnosis of ischaemic coronary heart disease. J Cardiovasc Risk 2002; 9: 41–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Denollet J. Type D personality. A potential risk factor refined. J Psychosom Res 2000; 49: 255–66, [INFOTRIEVE], [CROSSREF], [CSA]
- Denollet J, Sys S U, Stroobant N, Rombouts H, Gillebert T C, Brutsaert D L. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417–21, [INFOTRIEVE], [CROSSREF], [CSA]
- Lane D, Carroll D, Ring C, Beevers D G, Lip G Y. In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. Int J Epidemiol 2002; 31: 1179–82, [INFOTRIEVE], [CROSSREF], [CSA]
- Lauzon C, Beck C A, Huynh T, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 2003; 168: 547–52, [INFOTRIEVE], [CSA]
- Lane D, Carroll D, Lip G Y. Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?. J Am Coll Cardiol 2003; 42: 1808–10, [INFOTRIEVE], [CROSSREF], [CSA]
- Ketterer M W, Mahr G, Cao J J, Hudson M, Smith S, Knysz W. What's “unstable” in unstable angina?. Psychosomatics 2004; 45: 185–96, [INFOTRIEVE], [CROSSREF], [CSA]
- Jow G M, Yang T T, Chen C L. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 2006; 90: 21–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Brunner J, Parhofer K G, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 2002; 35: 1–5, [INFOTRIEVE], [CROSSREF], [CSA]
- Manfredini R, Caracciolo S, Salmi R, Boari B, Tomelli A, Gallerani M. The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link. J Int Med Res 2000; 28: 247–57, [INFOTRIEVE], [CSA]
- Bush D E, Ziegelstein R C, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after myocardial infarction. Am J Cardiol 2001; 88: 337–41, [INFOTRIEVE], [CROSSREF], [CSA]
- Welin C, Lappas G, Wilhelmsen L. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000; 247: 629–39, [INFOTRIEVE], [CROSSREF], [CSA]
- van Melle J P, de Jonge P, Spijkerman T A, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814–22, [INFOTRIEVE], [CROSSREF], [CSA]
- Tsigos C, Chrousos G P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53: 865–71, [INFOTRIEVE], [CROSSREF], [CSA]
- Musselman D L, Evans D L, Nemeroff C B. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55: 580–92, [INFOTRIEVE], [CROSSREF], [CSA]
- Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000; 247: 188–97, [INFOTRIEVE], [CROSSREF], [CSA]
- Colao A, Pivonello R, Spiezia S, et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84: 2664–72, [INFOTRIEVE], [CROSSREF], [CSA]
- Gold P W, Gabry K E, Yasuda M R, Chrousos G P. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am 2000; 31: 37–62, [CROSSREF], [CSA]
- Joynt K E, Whellan D J, O'Connor C M. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003; 54: 248–61, [INFOTRIEVE], [CROSSREF], [CSA]
- Remme W J. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19: F62–71, suppl F[INFOTRIEVE], [CSA]
- Carpeggiani C, L'Abbate A, Landi P, et al. Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. Int J Cardiol 2004; 96: 361–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Carney R M, Freedland K E, Veith R C, et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999; 45: 458–63, [INFOTRIEVE], [CROSSREF], [CSA]
- Carney R M, Blumenthal J A, Stein P K, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024–8, [INFOTRIEVE], [CSA]
- Carney R M, Freedland K E, Stein P K, Skala J A, Hoffman P, Jaffe A S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000; 62: 639–47, [INFOTRIEVE], [CSA]
- Cohen H, Kotler M, Matar M, Kaplan Z. Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J 2000; 2: 296–301, [INFOTRIEVE], [CSA]
- Tucker P, Adamson P, Miranda R, Jr, et al. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol 1997; 17: 370–6, [INFOTRIEVE], [CROSSREF], [CSA]
- Kronfol Z, Remick D G. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683–94, [INFOTRIEVE], [CROSSREF], [CSA]
- Thomas A J, Davis S, Morris C, Jackson E, Harrison R, O'brien J T. Increase in interleukin-1β in late-life depression. Am J Psychiatry 2005; 162: 175–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161: 271–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Saadeddin S M, Habbab M A, Ferns G A. Markers of inflammation and coronary artery disease. Med Sci Monit 2002; 8: RA5–12, [INFOTRIEVE], [CSA]
- Ridker P M, Cannon C P, Morrow D, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Wirleitner B, Rudzite V, Neurauter G, et al. Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 2003; 33: 550–4, [INFOTRIEVE], [CROSSREF], [CSA]
- Musselman D L, Tomer A, Manatunga A K, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153: 1313–7, [INFOTRIEVE], [CSA]
- Kop W J, Gottdiener J S, Tangen C M, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89: 419–24, [INFOTRIEVE], [CROSSREF], [CSA]
- Vikenes K, Farstad M, Nordrehaug J E. Serotonin is associated with coronary artery disease and cardiac events. Circulation 1999; 100: 483–9, [INFOTRIEVE], [CSA]
- Golino P, Piscione F, Willerson J T, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New Engl J Med 1991; 324: 641–8, [INFOTRIEVE], [CSA]
- Serebruany V L, Glassman A H, Malinin A I, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108: 939–44, [INFOTRIEVE], [CROSSREF], [CSA]
- Schins A, Hamulyak K, Scharpe S, et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci 2004; 24(76)637–50, [CROSSREF], [CSA]
- Ziegelstein R C, Fauerbach J A, Stevens S S, Romanelli J, Richter D P, Bush D E. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818–23, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Honig A, Lousberg R, van Os J, van den Berg E J, van Praag H M. Clinical correlates of depression following myocardial infarction. Int J Psychiatry Med 2001; 31: 255–64, [INFOTRIEVE], [CROSSREF], [CSA]
- Ades P A, Waldmann M L, McCann W J, Weaver S O. Predictors of cardiac rehabilitation participation in older coronary patients. Arch Intern Med 1992; 152: 1033–5, [INFOTRIEVE], [CROSSREF], [CSA]
- Glazer K M, Emery C F, Frid D J, Banyasz R E. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 2002; 22: 40–6, [INFOTRIEVE], [CROSSREF], [CSA]
- Strik J J, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62: 783–9, [INFOTRIEVE], [CSA]
- Shapiro P A, Lesperance F, Frasure-Smith N, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-depressant Heart Attack Trial. Am Heart J 1999; 137: 1100–6, [INFOTRIEVE], [CSA]
- Serebruany V L, Gurbel P A, O'Connor C M. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharm Res 2001; 43: 453–62, [CSA]
- Weinrieb R M, Auriacombe M, Lynch K G, Lewis J D. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005; 4: 337–44, [INFOTRIEVE], [CROSSREF], [CSA]
- Wheatley D. Anxiolytic drug use in cardiovascular disease: an overview. Psychopharmacol Bull 1984; 20: 649–59, [INFOTRIEVE], [CSA]
- Melsom M, Andreassen P, Melsom H, Hansen T, Grendahl H, Hillestad L K. Diazepam in acute myocardial infarction: clinical effects and effects on catecholamines, free fatty acids, and cortisol. Br Heart J 1976; 38: 804–10, [INFOTRIEVE], [CSA]
- Nitenberg A, Marty J, Blanchet F, et al. Effects of flunitrazepam on left ventricular pressure, coronary haemodynamics and myocardial metabolism in patients with coronary artery disease. Br J Anaesth 1983; 55: 1179–84, [INFOTRIEVE], [CSA]
- Sauer W H, Berlin J A, Kimmel S E. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104: 1894–8, [INFOTRIEVE], [CSA]
- Kagoshima M, Miyashita Y, Takei K, et al. Acute myocardial infarction in elderly patients: medical and social problems [in Japanese]. J Cardiol 2000; 35: 267–75, [INFOTRIEVE], [CSA]
- Dobson K S. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57: 414–9, [INFOTRIEVE], [CROSSREF], [CSA]
- Craighead W E, Craighead L W. The role of psychotherapy in treating psychiatric disorders. Med Clin North Am 2001; 85: 617–29, [INFOTRIEVE], [CROSSREF], [CSA]
- Blumenthal J A, Babyak M A, Moore K A, et al. Effects of exercise training on older adults with major depression. Arch Intern Med 1999; 159: 2349–56, [INFOTRIEVE], [CROSSREF], [CSA]
- Babyak M, Blumenthal J A, Herman S, et al. Exercise treatment for major depression maintenance of therapeutic benefit at 10 months. Psychosom Med 2000; 62: 633–8, [INFOTRIEVE], [CSA]
- Blumenthal J A, Babyak M A, Carney R M, et al. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004; 36: 746–55, [INFOTRIEVE], [CROSSREF], [CSA]
- Taylor C B, Houston-Miller N, Ahn D K, Haskell W, DeBusk R F. The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients. J Psychosom Res 1986; 30: 581–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Dracup K, Moser D K, Marsden C, Taylor S E, Guzy P M. Effects of a multidimensional cardiopulmonary rehabilitation program on psychosocial function. Am J Cardiol 1991; 68: 313–4, [CROSSREF], [CSA]
- Holmback A M, Sawe U, Fagher B. Training after myocardial infarction: lack of long-term effects on physical capacity and psychological variables. Arch Phys Med Rehabil 1994; 75: 551–4, [INFOTRIEVE], [CSA]
- Taylor C B, Youngblood M E, Catellier D, et al. ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62: 792–8, [INFOTRIEVE], [CROSSREF], [CSA]